Publications

Book Chapter

  1. Invited to write a book chapter Patravale V., Joshi M., Nanocarriers for imaging applications, in:
    F. Monzer
    (Ed.) Colloids in Drug Delivery, CRC Press, Boca Raton, 2010, pp. 563-611
  2. Invited to write a book chapter Chuagule M., Joshi M “Liposomes based drug delivery for the
    treatment of
    lung cancer” Encyclopedia of Nanoscience and Nanotechnology, American Scientific publishers to be published in 2015.

Original Research Articles

  1. Joshi M and Patravale V (2006) Formulation and evaluation of Nanostructured Lipid Carrier (NLC)-based gel of Valdecoxib. Drug Dev Ind Pharm 32:911-918.
  2. Shah K, Date A, Joshi M and Patravale V (2007) Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 345:163-171.
  3. Joshi M, Pathak S, Sharma S and Patravale V (2008) Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject. Int J Pharm 364:119-126.
  4. Joshi M, Pathak S, Sharma S and Patravale V (2008) Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria. Int J Pharm 362:172-178.
  5. Joshi M and Patravale V (2008) Nanostructured lipid carrier (NLC) based gel of celecoxib. Int J Pharm 346:124-132.
  6. Shah K, Joshi M and Patravale V (2009) Biocompatible microemulsions for fabrication of glyceryl monostearate solid lipid nanoparticles (SLN) of tretinoin. J Biomed Nanotechnol 5:396-400.
  7. Joshi M, Unger W, van Beelen A, Bruijns S, Litjens M, van Bloois L, Kalay H, van Kooyk Y and Storm G (2011) DC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations. Int J Pharm 416:426-432.
  8. Patil S, Joshi M, Pathak S, Sharma S and Patravale V (2012) Intravenous beta-artemether formulation (ARM NLC)  as  a  superior  alternative  to  commercial  artesunate  formulation.  The  Journal  of  antimicrobial chemotherapy 67:2713-2716.
  9. Unger W, van Beelen A, Bruijns S, Joshi M, Fehres C, van Bloois L, Verstege M, Ambrosini M, Kalay H, Nazmi K, Bolscher J, Hooijberg E, de Gruijl T, Storm G and van Kooyk Y (2012) Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells. Journal of controlled release 160:88-95.
  10. Jain S, Basu H, Prabhu P, Soni U, Joshi M, Mathur, D, Patravale V, Sharma S and Pathak S (2014) Parasite Impairment by Targeting Plasmodium-Infected RBCs Using Glyceryl-dilaurate Nanostructured Lipid Carriers. Biomaterials 35: 6636-6645.
  11. Kain V, Ingle K, Prabhu S, Serhan C., Joshi M, and Halade G (2015) Resolvin D1 activates inflammation resolving  response  at  splenic  and  ventricular  site  following  myocardial  infarction  leading  to  improved ventricular function, Journal of Molecular and Cellular Cardiology 84: 24-35, 2015.
  12. Venkatesan N, O’Donnell J N, Joshi M, Nguyen H, Rhodes N, Chapman R. and Scheetz M, A simple, rapid, accurate, and precise method of measuring vancomycin concentrations in rat plasma via high-performance liquid chromatography (HPLC) communicated to Biomedical Chromatography B, June 2015.
  13. Joshi M, Oesterling B., Wu C., Gwizdz N., Pais G., Briyal S. and Gulati A. Evaluation of liposomal nanocarriers loaded with ETB receptor agonist, IRL-1620, using cell based assays communicated to Neuroscience, August 2015

Review Articles

  1. Date A, Joshi M and Patravale V (2007) Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev 59:505-521.
  2. Joshi M and Muller R (2009) Lipid nanoparticles for parenteral delivery of actives. Eur J Pharm Biopharm 71:161-172.
  3. Joshi M, Unger W, Storm G, van Kooyk Y and Mastrobattista E (2012) Targeting tumor antigens to dendritic cells using particulate carriers. Journal of controlled release 161:25-37.
  4. Prabhu P, Patravale V and Joshi M (2012) Nanocarriers for Effective Topical Delivery of Anti-Infectives. Current Nanoscience 8:491-503.
  5. Mehendale R, Joshi M and Patravale VB (2013) Nanomedicines for treatment of viral diseases. Critical reviews in therapeutic drug carrier systems 30:1-49.
  6. Oesterling B, Gulati A and Joshi M (2014) Nanocarrier Based Approaches for Treatment and Detection of Alzheimer's disease. Journal of Nanoscience and Nanotechnology 14:137-156.
  7. Li W, Joshi M, Singhania S, Ramsey K, Murthy A (2014) Peptide Vaccine: Progress and Challenges, published in the special issue: Peptide Vaccine, Vaccines 2, 515-536.
  8. Prabhu R, Patravale V and Joshi M (2015) Polymeric nanoparticles for targeted treatment in oncology: Current insights. International Journal of Nanomedicine, 10, 1001-1018.

General Publications/ editorials, letters, viewpoints

  1. Joshi M and Patravale V (2003) Solid Lipid Nanoparticles: Potential in Drug Delivery, in Souvenir of 5th International symposium on innovations in pharmaceutical sciences and technology (arranged by BVPERD, Ahmadabad), Mumbai, India.
  2. Joshi M and Patravale V (2005) Nanocarriers for Diagnostic Applications, in Souvenir of 1st Indo-Japanese Conference Mumbai, India.
  3. Joshi M and Patravale V (2006) Future Nanotechnology In Pharma Industry, in Pharmabiz Mumbai, India.
  4. Joshi M (2013) Research Highlights from the latest articles in Nanomedicine. Nanomedicine, Future Medicine 8:1-3.
  5. Joshi M (2014) Interviewed for Volunteer spotlight section; Volunteering: a way to connect, build, and change in Controlled Release Society’s newsletter, Volume 31, No 6.

Invited Speaker

  1. Joshi M, Improvement of Anti-Tumor Responses by DC-SIGN Mediated Antigen-Targeting Using Glycan Modified Liposomes: A Potential Anticancer Vaccine at 3rd International Conference on Pharmaceutics & Novel Drug Delivery Systems, April 08-10, 2013 Chicago, USA.
  2. Joshi M, Lipid Nanoparticle technology for formulation of cosmetics at 2nd International Conference and exhibition on Cosmetology and trichology, November 12-14, 2013, Chicago, IL, USA.
  3. Joshi M, Targeted delivery of tumor antigens to dendritic cells for efficient vaccination, 3rd World Immunology Online Conference, March 25-27, 2014.
  4. Joshi M, Nanocarrier based drug delivery systems, Presented to Master of Pharmacy students at AISSMS College of Pharmacy, Pune, India, April 18th, 2014.
  5. Joshi M, Targeted delivery of tumor antigens to dendritic cells for efficient vaccination, La Crosse BioResearch Forum, Overholt auditorium (Gundersen campus in La Crosse), La Crosse, WI 54601, July 16th, 2015.

Conference Session Chair

  1. Vaccine development-1, 3rd World Immunology Online Conference, March 25-27, 2014.

Proceedings

  1. Joshi M, Ansari A, Saini T, Shete J and Mourya V (2002) Investigation on Celecoxib-Cyclodextrin interactions, in 11th Symposia on Cyclodextrins, Iceland.
  2. Joshi M, Saini T, Shete J and Mourya V (2002) Development of Cyclodextrin Based Topical Formulation of Dithranol, in 11th Symposia on Cyclodextrins, Iceland.
  3. Joshi M and Patravale V (2005) Comparative Evaluation of Valdecoxib Solid Lipid Nanoparticles Based Gel and Micellar gel, in 32nd Annual meeting and exposition of the controlled release society, Miami, Florida.
  4. Joshi M and Patravale V (2005) Nanostructured lipid carriers (NLC) of β-artemether: potential in the treatment of cerebral malaria, in 1st Indo Japanese International Conference on Advances in Pharmaceutical Research and Technology, Mumbai, India.
  5. Shah K, Joshi M and Patravale V (2005) Comparative Evaluation of Microemulsion Templates and Solvent Emulsification-Diffusion Technique for the Production of Solid Lipid Nanoparticles, in 32nd Annual meeting and exposition of the controlled release society, Miami, Florida.
  6. Joshi M and Patravale V (2006) Microemulsion Preconcentrate for Oral Delivery of beta-Artemether, in 33rd Annual meeting and exposition of the Controlled Release Society Austria.
  7. Joshi M, Nikolic S and Muller R (2008) Synergistic UV protection efficacy of NLC loaded with ternary sunscreen mixture, in 35th Annual meeting and exposition of the Controlled Release Society, New York City, NY. (Podium)
  8. Prabhu P, Joshi M, Pathak S, Sharma S and Patravale V (2012) Nanostructured Lipid Carriers (NLC): Exploring potential as vaccine adjuvants, in 4th Indo-Japanese International Joint Symposium on Overcoming Intractable Infectious Diseases Prevalent in Asian Countries, Tokyo, Japan.
  9. Joshi M, Unger W, Litjens M, van Bloois L, Kalay H, Sparwasser T, Storm G and van Kooyk Y (2013) Improvement of Anti-Tumor Responses By DC-SIGN Mediated Antigen-Targeting Using Glycan Modified Liposomes: A Potential Anticancer Vaccine, in 3rd International Conference on Pharmaceutics & Novel Drug Delivery Systems, Phamaceut. Anal. Acta, Northbrook, IL. (Podium)
  10. Joshi M (2013) Lipid Nanoparticle technology for formulation of cosmetics, in 2nd International Conference and exhibition on Cosmetology and trichology p 93, Journal of Clinical and Experimental Dermatology, Chicago, IL. (Podium)

Poster/Podium presentations

  1. Joshi M, Darange D, Saini T and Mourya V (2001) Molecular Inclusion of Celecoxib in Cyclodextrins, in 53rd Indian Pharmaceutical Congress, New Delhi, India.
  2. Joshi M, Jain J and Patravale V (2003) A new method for colorimetric estimation of beta Artemether, in 55th Indian Pharmaceutical Congress Chennai, India.
  3. Joshi M, Mandawgade S and Patravale V (2003) Microemulsion based nanoparticulate drug delivery system, in 11th National conference on surfactants, emulsions and biocolloids Institute of Chemical Technology, Mumbai, India.
  4. Joshi M, Karkhanis D and Patravale V (2003) Isolation and quantification of pharmaceutically and cosmetically important constituents of Rice Bran Wax, in 5th International symposium on innovations in pharmaceutical sciences and technology (arranged by BVPERD, Ahmedabad) Mumbai, India.
  5. Joshi M and Patravale V (2004) Solid Lipid Nanoparticles: Effect of Cryoprotection, in fifth international symposium on Advances in Technology and Business Potential of New Drug Delivery Systems (Organized by Controlled Released Society, Indian Chapter) Mumbai, India.
  6. Joshi M and Patravale V (2005) Comparative Evaluation of Celecoxib Solid Lipid Nanoparticles Based Gel And Micellar Gel, in 1st Indo-Japanese Conference, Mumbai, India.
  7. Joshi M and Patravale V (2005) NanOsip® of beta-Artemether, in 6th Int Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems, Mumbai, India.
  8. Joshi M and Patravale V (2005) Nanostructured Lipid Carriers (NLC) of  beta Artemether: Potential for the Treatment of Cerebral Malaria, in 1st Indo-Japanese Conference, Mumbai, India.
  9. Joshi M and Patravale V (2005) Solid Lipid Nanoparticles Based Gel of Celecoxib’, in National Seminar on Polymers, Surfactants & Gels, Baroda, India. (Podium)
  10. Joshi M, Pattani A and Patravale V (2005) NanOjelly® of Celecoxib, in 56th Indian Pharmaceutical Congress, Kolkata, India (Podium)
  11. Joshi M, Pattani A and Patravale V (2005) Solid Lipid Nanoparticles Based Gel of Valdecoxib, in 6th Int Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems Mumbai, India.
  12. Joshi M, Rege M, Pathak S, Sharma S and Patravale V (2006) Artemether NanOsorb: A Nanocarrier Based Potent Antimalarial Formulation, in Indo US symposium on nanotechnology in advanced drug delivery, NIPER, Chandigarh, India.
  13. Joshi M, Rege M, Pathak S, Sharma S and Patravale V (2007) Lipid Nanocarrier Based Potent Antimalarial formulations, in 32nd Mahabaleshwar Seminar on parasite Immunology and Immunogenetics, Mahabaleshwar, India.(Podium)
  14. Joshi M, Rege M, Pathak S, Sharma S and Patravale V (2007) Lipid Nanocarrier based Potent Antimalarial Formulations, in 1st Summer school on Nanotechnology in Advanced Drug Delivery, NIPER, Chandigarh, India.
  15. Joshi M, Rege M, Pathak S, Sharma S and Patravale V (2007) Nanoject : Nanostructured lipid Carrier NLC Based Intravenous injection of Artemether, in 7th International Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems Mumbai, India.
  16. Joshi M, Sharma S and Patravale V (2007) NanOsorb: Lipid Nanocarrier based antimalarial formulation of Artemether, in American Association of Pharmaceutical Scientists Annual Meeting San Diego, CA, USA.
  17. Joshi M, Anselmi C and Keck C (2007) Skin-Friendly Sun Protection By Nano-Carrier Technology, in Menopause Andropause Anti-Aging 2007, Der Menopause kongress, Vienna, Austria.
  18. Joshi M and Patravale V (2007) Lipid Based Nanocarriers of Beta Artemether: Defying Conventional Anti- malarial Therapeutics, in AAPS Annual Meeting and Exposition, San Diego, CA, USA.
  19. Joshi M, Pardeike J, Nikolic S and Müller R (2008) Nanostructured Lipid Carriers for Dermal Application : Recent Advances, in 7th International Conference and Workshop on Biological Barriers and Nanomedicine, University of Saarland, Saarbrucken, Germany.
  20. Joshi M, Sharma S and Patravale V (2008) Lipid Nanocarrier Based Potent Anti-malarial formulations, in European Workshop on Particulate Systems Free University of Berlin, Berlin. (Podium)
  21. Müller R, Xia Q and Joshi M (2008) Hydrophobic Lipid Nanoparticles For Dermal Delivery, in Deutsche Pharmazeutische Gesellschaft, Bonn, Germany.
  22. Patil S, Soni U, Joshi M, Pathak S, Sharma S and Patravale V (2008) Parenteral lipid nanocarriers of beta artemether- a comparison, in 8th International Symposium on Advances in Technology and Business Potential of New Drug Delivery Systems, Mumbai, India.
  23. Joshi M, Unger W, Litjens M, van Bloois L, Kalay H, Sparwasser T, Storm G and van Kooyk Y (2009) Improving anti-tumor responses by DC-SIGN mediated antigen-targeting using glycan modified liposomes: A potential anticancer vaccine, in 2nd European Conference for Clinical Nanomedicine (CLINAM) Basel, Switzerland.
  24. Joshi M, Unger W, Litjens M, van Bloois L, Kalay H, Sparwasser T, Storm G and van Kooyk Y (2010) Improving Anti-Tumor Responses By Dc-SIGN Mediated Antigen-Targeting Using Glycan Modified Liposomes: A Potential Anticancer Vaccine, in 8th European Workshop on Particulate Systems, Châtenay- Malabry, Paris, France. (Podium)
  25. Joshi M, Park G, Sansom S and Gilchrist A (2012) Assessment of metabolic activity to ascertain the effects of the proteasome inhibitor bortezomib on RANKL differentiated and undifferentiated RAW 264.7 cells, in American Association of Pharmaceutical Scientists Annual Meeting, Chicago, IL.
  26. Fajiculay J, Campigotto M, Park G, Joshi M and Gilchrist A (2012) Differential effects of bortezomib on osteoblastic & osteosarcoma cell lines suggest resistance may be through anti-apoptotic Akt pathway, in CMIDD 17th Annual Drug Discovery Symposium, Chicago, IL.
  27. Fajiculay J, Campigotto M, Park G, Joshi M and Gilchrist A (2012) Differential effects of bortezomib on osteoblastic and osteosarcoma cell lines suggest resistance may be through anti-apoptotic Akt pathway, in ASHP Clinical Mid-Year Meeting, Las Vegas, NV.
  28. Fajiculay J, Campigotto M, Park G, Joshi M and Gilchrist A (2013) Differential effects of bortezomib to osteoblastic and osteosarcoma cell lines indicates resistance may be through the anti-apoptotic Akt pathway in American Pharmacist Association Annual meeting, Los Angeles,CA.
  29. Jain S, Prabhu P, Soni U, Joshi M, Pathak S, Sharma S and Patravale V (2013) Nanostructured Lipid Carriers: Exploring Immunomodulatory Potential as Vaccine Adjuvants in International Symposium on Drug Discovery for Infectious Diseases and Cancer, Mumbai, India.
  30. Patil S, Joshi M, Pathak S, Sharma S and Patravale V (2013) Artemether nanostructured lipid carriers: Is it safe for intravenous administration?, in The South Asian Chapter of American College of Clinical Pharmacology: 6th International Conference on Innovation in 21st Century: Clinical Pharmacology in Current and Future environment, , Mumbai, India.
  31. Park G, Gilchrist A and Joshi M (2013) Intracellular delivery of bortezomib using mitochondria targeted ceramide liposomes, in Nanomedicine alliance symposium, Rockville, MD.
  32. Park G, Gilchrist A and Joshi M (2013) Encapsulation in ceramide lipid nanoparticles enhances bortezomib- induced effects on metabolic activity, in ASPET annual meeting at Experimental Biology Boston, MA, USA.
  33. Park G, Gilchrist A and Joshi M (2013) Enhanced Apoptosis with Bortezomib Encapsulated in Liposomes: A Comparison of Cationic and Ceramide Liposomes, American Association of college of Pharmacy (AACP) annual meeting, Chicago, July 13-17, 2013
  34. Ralhan P, Gulati A and Joshi M (2013) PEGylated liposomal formulations of ETB receptor agonist, IRL-1620, for the treatment of cerebral ischemia, in 118th Annual Osteopathic Medical Conference and Exposition Las Vegas, NV.
  35. Park G, Pichlik J, Gilchrist A and Joshi M (2013) Efficacious intracellular delivery of bortezomib encapsulated in liposomes: a comparison between cationic and ceramide liposomes, in ASHP Clinical Mid-Year Meeting, Orlando, FL, USA.
  36. Jain S, Joshi M, Pathak S, Sharma S and Patravale V (2013) Nanostructured Lipid Carriers of Artemether in Combination with Clindamycin for Effective Treatment of Malaria, in American Association of Pharmaceutical Scientists Annual Meeting, San Antonio, TX, USA.
  37. Oesterling B, Pais G, Briyal S, Gulati A and Joshi M (2014) Efficacy of liposomal nanocarriers in targeted delivery of ETB receptor agonist, IRL-1620 for the treatment of Alzheimer’s Disease, in 41st Annual Meeting Exposition of the Controlled Release Society, Chicago. IL.
  38. Park G, Pichlik J, Gilchrist A and Joshi M (2014) Enhanced Apoptosis Induction by Bortezomib loaded in Liposomal Nanocarriers: A Comparison between Cationic and Ceramide Liposomes, in 41st Annual Meeting & Exposition of the Controlled Release Society, Chicago, IL.
  39. Hoang A., Joshi M. (2014) Formulation, Characterization, and Stability of Cationic C6-Ceramide Liposomes Loaded with Betulinic Acid in American Association of Pharmaceutical Scientists Annual Meeting, San Diego, CA, USA.
  40. Kain V., Ingle K. A., Prabhu S. D., Serhan C. N., Joshi M. and Halade G V. (2015) RvD1 Primes Resolution of Inflammation Following Myocardial Infarction Leading To Improved Ventricular Function, Experimental Biology, Boston, MA, USA Mar 28-Apr 1, 2015. (Podium and Poster presentation)
  41. Park G, Pichlik J, Gilchrist A and Joshi M (2015) Enhanced Apoptosis Induction by Bortezomib loaded in Liposomal Nanocarriers: A Comparison between Cationic and Ceramide Liposomes, Submitted to AICHE Midwest regional conference, March 2015.(Podium)
  42. Prabhu P., Joshi M, Pathak S, Sharma S., V. Patravale (2015) Nanostructured Lipid Carriers (NLC) of Artemether-Lumefantrine combination for intravenous malaria therapy Submitted to 1st European Conference on Pharmaceutics: Drug Delivery, 13-14 April, Reims, France.
  43. Wu C., Briyal S., Pais G., Gulati A. and Joshi M. (2015) Evaluation of liposomal nanocarriers loaded with etb receptor agonist, IRL-1620, using cell based assays, Society of Neuroscience Chicago Chapter meeting, Northwestern memorial conference center, Chicago, March 20th, 2015.
  44. Gwizdz N., Wu C., Briyal S., Pais G., Gulati A. and Joshi M. (2015) In Vitro Cell Based Assays to Evaluate ETB Receptor Agonist: IRL-1620 Loaded PEGylated Liposomes in American Association of Pharmaceutical Scientists Annual Meeting, Orlando, FL, USA.

 

 

 

 

 

Medha D Joshi

Assistant Professor of Pharmaceutical Sciences
Midwestern University
Downers Grove, Illinois, USA
Phone: 630-515-6963
E-mail: mjoshi@midwestern.edu